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CD25
+CD4
+ regulatoryTcellssuppressTcellactivationandregulatemultipleimmunereactionsininvitroandinvivostudies.To
deﬁne the regulatory function of human CD25
+CD4
+ T cells at various stages of maturity, we investigated in detail the functional
diﬀerences of CD25
+CD4
+ T cells from thymocytes, cord blood (CB), and adult peripheral blood (APB). CB CD25
+CD4
+ Tc e l l s
displayedlow-FOXP3proteinexpressionlevelandhadnosuppressiveactivity.Incontrast,CD25
+CD4
+ Tcellsfromthymocytesor
APB expressed high expression level of FOXP3 protein associated with signiﬁcant suppressive activity. Although CB CD25
+CD4
+
T cells exhibited no suppressive activity, striking suppressive activity was observed following expansion in culture associated
with increased FOXP3 expression and a shift from the CD45RA
+ to the CD45RA
− phenotype. These functional diﬀerences in
CD25
+CD4
+ T cells from Thy, CB, and APB hence suggest a pathway of maturation for Treg in the peripheral immune system.
Copyright © 2008 Wakae Fujimaki et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Naturally occurring regulatory T cells (Treg) are character-
istically CD25+CD4+ and display strong suppressive activity
against responder cell reactivity, although Treg themselves
are in an anergic state, that is, they do not proliferate
nor produce interleukin (IL)-2 on stimulation [1]. These
Treg have pivotal role in controlling autoimmunity, tumor
immunity, transplantation tolerance, maternal tolerance to
the fetus, allergy, and microbial immunity [2–4]. CD25 is
theﬁrstrecognizedmarkerforTreg,withCD152(cytotoxicT
lymphocyte-associatedantigen-4)orglucocorticoid-induced
tumor necrosis factor receptor-related protein (GITR) being
alsoused[5–7].However,sincethesemoleculesareexpressed
also on activated T cells, they are not speciﬁc markers for
Treg. On the other hand, forkhead box P3 (FOXP3), a mem-
ber of the well-known and diverse forkhead transcription
factor family, is a master switch in Treg diﬀerentiation and
function,whileappearingtobeaspeciﬁcmarkerforTreg[8–
12].
SeveralstudieshaveshownthatTregaregeneratedwithin
the thymic medulla in response to high-aﬃnity interactions
with thymic epithelial cells [13], prior to exiting to the
periphery.RecentworksuggestedthattheHassal’scorpuscles
have a critical role in the generation of human Treg within
the thymus [14]. In contrast to knowledge regarding Treg
development in thymus, the pathway of maturation for
Treg in the peripheral immune system is still obscure. For
this purpose, it is important to characterize the regulatory
function of human CD25+CD4+ T cells at various stages
of maturity. While the functions of Treg from thymocytes
(Thy), cord blood (CB), or adult peripheral blood (APB)2 Clinical and Developmental Immunology
have been examined previously [15–19], it is diﬃcult to
concisely summarize the functional diﬀerences of Treg from
these studies since the observed results were not consistent
and since the functional assays for Thy, CB, and APB Treg
were not simultaneously performed to facilitate comparison
among these diﬀerent components. Interestingly, a subset of
na¨ ıve type Treg was identiﬁed recently in APB [17, 20],where
it had been previously thought that the Treg population
was of the CD45RO+ activated/memory subset. The na¨ ıve
CD45RA+ Treg is predominant in the CB Treg population
[18], and is prominent in young adults while decreasing with
age [20]. However, details regarding the maturation process
of na¨ ıve type APB Treg and CB Treg have not been heretofore
conclusively clariﬁed.
We previously examined the process involved in post-
thymic maturation of conventional CD4+ T cells by inves-
tigating the antigen-reactivity status of CD4+ Tc e l l sf r o m
Thy, CB, and APB [21, 22]. Conventional CD4+ Tc e l l s
migrating from the thymus appear to be required for the
acquisition of full reactivity. The immaturity of conventional
CD4+ T cells from CB is thought to aﬀect the pathogen-
esis of infectious diseases [23, 24]. Since CB is used for
stem cell transplantation, CB Treg function is especially
important in understanding the low occurrence of graft-
versus-host disease (GVHD) in this clinical setting [25, 26].
Furthermore, it is important to understand the unique
immunological reactivity of the newborn. We have therefore
focused our eﬀort on determining the regulatory function of
CD25+CD4+ T cells at various stages of maturity.
In the present study, we performed comprehensive
comparative analysis of CD25+CD4+ T cells from APB, CB,
and Thy through multicolored staining of cell surface and
intracellular molecules, including FOXP3, and functional
assays. Interestingly, the suppressive activity of fresh CB
CD25+CD4+ T cells was lacking in contrast to that found
in APB CD25+CD4+ Tc e l l sa n dT h yC D 2 5 +CD4+ T cells.
However, expansion of the CB CD25+CD4+ T cells in vitro
resulted in the restoration of superior suppressive activity to
that of APB or Thy CD25+CD4+ T cells following expansion.
Based on our data, we propose a maturation pathway for
peripheral human CD25+CD4+ T cells and discuss the
potential biological implications of the unique functions
observed in the CB CD25+CD4+ T cells.
2. MATERIALS AND METHODS
2.1. PuriﬁcationofCD25+ andCD25−CD4+ Tcells
APB was obtained from healthy adult donors (24–52 years of
age) and CB was obtained from healthy full-term neonates
within 24 hours of delivery, after written informed consent
was obtained. APB and CB mononuclear cells were isolated
by Lymphoprep (Nycomed, Oslo, Norway) density gradient
centrifugation. Single-cell suspensions of thymocytes were
obtained from thymus fragments dissected from donors,
ranging in age from 2 months to 10 years, during corrective
cardiac surgery after obtaining written informed consent.
CD25+CD4+ and CD25−CD4+ T cells were isolated by
CD4+CD25+ regulatory T cell isolation kit (Miltenyi Biotec,
Auburn, Calif., USA). The resulting puriﬁed CD25+CD4+
and CD25−CD4+ T cellscontained<5% CD25−CD4+ Tc ell s
and 1% CD25+CD4+ T cells, respectively.
2.2. IsolationofCD45RA+ andRA−CD25+CD4+ Tcells
To isolate CD45RA+CD25+CD4+, CD45RA−CD25+CD4+,
and CD25−CD4+ T cells, CD4+ T cells were ﬁrst puri-
ﬁed by negative selection with the CD4 T cell Isolation
kit II (Miltenyi Biotec). Bead-selected CD4+ cells were
stained with anti-CD4-allophycocyanin (APC), anti-CD25-
phycoerythrin (PE), and anti-CD45RA-ﬂuoroscein isothio-
cyanate (FITC) antibodies (BD Biosciences), and sorted by
a FACSAria cell sorter (BD Bioscience, Franklin Lakes, NJ,
USA). After gating on the CD4+ lymphocytes, cells were
separated into 3 tubes on the basis of CD45RA and CD25
expression.
2.3. Preparationofantigen-presentingcells
Autologous mononuclear cells were used as antigen-
presenting cells. Prior to use as antigen-presenting cells, cells
were irradiated at 30 gray with a γ-ray irradiator and treated
with mitomycin C at 50μg/ml for 30 minutes at 37◦C.
2.4. Proliferationassay
RespondingCD25−CD4+ Tcells(2×104 cell/well)werestim-
ulated with anti-CD3/CD28-monoclonal antibody (mAb-)
coated beads (Dynal Biotech ASA, Oslo, Norway) in the
presence of antigen-presenting cells (2 × 104 cell/well) in
0.2-ml volumes in 96-well U-bottom plates for 96 hours.
CD25+CD4+ T cells were added in graded numbers as
indicated. Anti-CD3/CD28-mAb-coated beads as stimulants
were added at a 1 : 10 bead-to-responder cell ratio. Culture
media was RPMI 1640 supplemented with 10% fetal calf
serum (FCS; Invitrogen, Carlsbad, Calif., USA). Cultures
were pulsed with 37kBq of 3H-thymidine for the last 16
hours of culture period. Results were expressed as the mean
counts per minute of triplicate wells.
2.5. Cytokinemeasurement
Responding CD25−CD4+ Tc e l l s( 2× 105 cells/well) were
stimulated with anti-CD3/CD28-mAb-coated beads in the
presence of antigen-presenting cells (2 × 105 cells/well) in
0.2-ml volumes in 96-well U-bottom culture plates. Either
2 × 105 CD25+CD4+ T cells or none were then added. Anti-
CD3/CD28-mAb-coated beads as stimulants were added at a
1 : 3 bead-to-responder cell ratio. After 48 hours of culture,
the supernatants were collected from each well, and the
levels of IL-2 or those of transforming growth factor (TGF)-
β in the culture supernatants were measured by enzyme-
linked immunosorbent assay (ELISA; BD Biosciences). For
the proﬁling of cytokine production, IL-2, IL-4, IL-5, IL-
10, interferon (IFN)-γ, and tumor necrosis factor (TNF) α
levelsinsupernatantsweremeasuredusingacytometricbead
array kit (BD Bioscience), according to the manufacturer
instructions. All data were presented as picograms per mL.Wakae Fujimaki et al. 3
Table 1: Combinations of antibodies used in FACS analysis.
Fluorophore FITC PE PE-TR PerCP-Cy5.5 PE-Cy-7 APC APC-Cy7 Paciﬁc Blue
Surface staining(a) Ag CD45RO CD25 PI CD8 CD3 CD62L CD4 CD45RA
Clone UCHL1 4E3 SK1 SK7 Dreg56 RPA-T4 MEM-56
Intracellular staining(b)
Ag CD62L CD152 EMA CD8 CD4 CD25 - CD45RA
Clone Dreg56 BNI3 SK1 SK3 M-A251 MEM-56
Ag CD45RA FOXP3 - - CD152 CD25 CD4 CD8
Clone HI100 PCH101 BNI3.1 M-A251 RPA-T4 RPA-T8
(a)All Abs were added to cells except PI, and cells were stained for 20minutes. PI were added just before FACS analysis.
(b)All Abs were added to cells except anti-FOXP3-Ab and/or anti-CD152-Ab, and cells were stained for 20minutes. After cell ﬁxation and
permeabilization, anti-FOXP3-Ab and anti-CD152-Ab were added for intracellular staining.
2.6. Flowcytometricanalysis
For phenotypic analysis of mononuclear cells and thy-
mocytes, cells were stained with several combinations of
mAbs as shown in Table 1: anti-CD45RO-FITC (UCHL1),
anti-CD45RA-FITC (HI100), anti-CD62L-FITC (Dreg56),
anti-CD152-PE (BNI3), anti-CD8-peridinin chlorophyll
protein-cycrome 5.5 (PerCP-Cy5.5) (SK1), anti-CD3-PE-
Cy7 (SK7), anti-CD4-PE-Cy7 (SK3), anti-CD62L-APC
(Dreg56), anti-CD25-APC (M-A251), anti-CD4-APC-Cy7
(RPA-T4), anti-CD8-paciﬁc blue (RPA-T8), and anti-
CD152-biotin (BNI3.1, BD Biosciences), anti-CD25-PE
(4E3, Miltenyi Biotec, Auburn, Calif., USA), anti-FOXP3-PE
(PCH101, eBioscience, San Diego, CA), and anti-CD45RA-
paciﬁc blue (MEM-56, Caltag, Burlingame, Calif., USA).
Biotin conjugates were developed with streptoavidin-PE-
Cy7 (BD Biosciences). For cell surface staining, all Abs
were added to cells except propidium iodide (PI), and
cells were stained for 20 minutes. PI was added to unﬁxed
samples just prior to FACS analysis to exclude dead cells.
When performing intracellular staining for FOXP3 and/or
CD152, cell-surface staining was ﬁrst completed, and cells
were ﬁxed and permeabilized for intracellular staining.
For upper intracellular staining pattern in Table 1,1 %
formaldehyde and 0.5% saponin were used for ﬁxation
and permeabilizaion, respectively. For lower intracellular
staining pattern in Table 1, FOXP3 staining set (eBio-
science) was used according to the manufacturer instruc-
tions. Ethidium monoazide bromide (EMA) was added
prior to ﬁxation to exclude dead cells. Stained cells were
examined by eight-color ﬂow cytometric analysis using a
FACSAria cell sorter (BD Bioscience). Data analysis was per-
formed using FlowJo software (Treestar, San Carlos, Calif.,
USA).
For phenotypic conﬁrmation of the CD25+CD4+ and
CD25−CD4+ T cell preparation, cells were stained for
three-color analysis with several combinations of the
following mAbs: anti-CD4-FITC (RPA-T4), anti-CD8-PE
(RPA-T8), anti-CD45RA-FITC (HI100) and anti-CD45RO-
PE (UCHL1, BD Biosciences), anti-CD25-PE (4E3, Mil-
tenyi Biotec), and anti-CD3-phycoerythrin cyanin 5 (PC5)
(UCHT1, Immnunotech, Marseille, France). Analysis was
performed on a FACSCalibur using Cellquest software.
2.7. Westernblotting
Cells (2 × 105/ s a m p l e )w e r el y s e di nc e l ll y s i sb u ﬀer
(containing 10mM Tris-HCl (pH7.4), 1% Nonidet P-40,
0.1% sodium deoxycholate, 0.1% sodium dodecyl sul-
fate (SDS), 0.15M NaCl, 1mM ethylenediaminetetraacetic
acid (EDTA), 10μg/ml aprotinin, and 300μg/ml phenyl-
methylsulfonyl ﬂuoride). The cell lysates were subjected
to a 10% SDS-polyacrylamide gel electrophoresis under
reducing conditions, transferred to a polyvinylidene diﬂu-
oride membrane, and immunoblotted with mouse anti-
FOXP3 Ab (Abcam, Cambridge, Mass., USA) followed
by horseradish peroxidase-conjugated antimouse IgG (GE
Healthcare UK Ltd. Buckinghamshire, UK) as the second
Ab. The immunoblots were developed with Western Light-
ening Chemiluminescence Reagent Plus (PerkinElmer Life
Sciences. Inc., Boston, Mass., USA). As positive control for
Western blot analysis, recombinant human FOXP3 fusion
protein was produced by cloning full length human FOXP3,
which was generated by PCR, into the pcDNA4/HisMax
vector (Invitrogen).
2.8. ExpansioncultureofCD25+CD4+ Tcells
IsolatedCD25+CD4+ Tcellswereculturedat1×106 cells per
milliliter with anti-CD3/CD28 mAb-coated beads at a 1 : 10
bead-to-cell ratio and recombinant human IL-2 (Shionogi,
Osaka, Japan) at 100U/ml. For these cultures, since the addi-
tion of irradiated antigen-presenting cells was not helpful for
expansion, as reported previously [27], antigen-presenting
cells were not utilized. Cell cultures were split as needed. For
the last 24 hours of the culture period, cells were cultured
without IL-2. Culture media was RPMI 1640 supplemented
with 10% FCS, penicillin, and streptomycin. Recovered cells
were subjected to Percoll (density = 1.050) centrifugation.
Viable cells were obtained under density of 1.050.
3. RESULTS
3.1. PhenotypiccomparisonofCD25+CD4+ Tcells
populationsfromAPB,CB,andThy
To compare the phenotype of CD25+CD4+ Tc e l l sf r o m
APB, CB, and Thy, we ﬁrst performed eight-color staining4 Clinical and Developmental Immunology
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Figure 1: Predominance of CD45RA+ type CD25+CD4+ T cells in CB, and existence of CD45RA+ and CD45RO+ type CD25+CD4+ Tc e l l s
in APB and Thy. (a) Mononuclear cells or thymocytes were multistained with anti-CD3, anti-CD4, anti-CD8, anti-CD25, anti-CD45RA,
anti-CD45RO, anti-CD62L mAbs, and PI (Table 1). The proﬁles were gated for PI−CD3+CD8−CD4+ cells (left and middle columns) or
CD3+CD8−CD4+CD25+ cells (right column), and expression of CD45RA versus CD45RO was illustrated. Data are representative of 3
diﬀerent donors. (b) APB CD4+ T cells were stained with anti-CD4 and anti-CD25 mAbs. On the basis of CD4 and CD25 expression,
CD25high CD4+ cells, CD25intermediate CD4+ cells, and CD25negative CD4+ cells were sorted. Each cell population was lysed and immunoblotted
with anti-FOXP3 or anti-β-actin Ab. FOXP3 in human PBMC was detected at a lower position than the recombinant human FOXP3 fusion
protein used as positive control, since the recombinant human FOXP3 fusion protein contains approximately 4kDa of additional peptides
such as the 6xHis tag, Xpress epitope tag, and enterokinase recognition site, as described in Section 2 .
analysis to evaluate the T cell phenotype of each compart-
ment (Figure 1(a)). Left and middle columns were gated
for PI−CD3+CD8−CD4+ cells and right column was gated
additionally for cells shown in the left column that highly
expressed CD25. As shown in the upper row of the left
column of Figure 1(a),A P BC D 4 + T cells were divided into
three populations diﬀering in CD25 expression levels, which
were high, intermediate, and negative. Since FOXP3 protein
level is a reliable marker for deﬁning Treg, we next examined
its expression in these T cell populations. As shown in
Figure 1(b), Western blotting for FOXP3 protein expression
conﬁrmed that CD25high CD4+ T cells expressed the highestWakae Fujimaki et al. 5
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Figure 2: Lack of suppressive activity and absence of an anergic state by CB CD25+CD4+ Tc e l l s .CD4+CD25+ and CD4+CD25− Tc e l l sw e r e
puriﬁed by a magnetic microbead system. (a) Cells were lysed and immunoblotted with anti-FOXP3 Ab (top panel) or anti-β-actin Ab
(bottom panel). (b) Cells were stimulated with anti-CD3/CD28-mAb-coated beads under the indicated conditions. Cell proliferation was
assessed by 3H-thymidine uptake on day 4. Data are representative of 5 diﬀerent donors.
level of FOXP3 protein, with this population being Treg.
In CB and Thy, since cells expressing intermediate level
of CD25 were not so prominent, it was relatively easy to
identify the Treg population as being cells expressing high
levels of CD25+ (Figure 1(a), middle and bottom rows of
left column). The percentages of CD4+ T cells with high
CD25 expression were 5 ± 1% in APB (mean ± SD of 10
diﬀerent donors), 7 ± 2% in CB (n = 10), and 9 ± 4%
in Thy (n = 4). Although CD45RA+ and CD45RO+ were
abundantly expressed on APB CD4+ T cells (Figure 1(a),
middle of upper row), CD45RO+ was predominantly found
on the gated CD25high CD4+ Tc e l ls u b s e t( Figure 1(a),r i g h t
of upper row; 27 ± 11% CD45RA+ and 66 ± 6% CD45RO+,
n = 3). In CB, the CD45RA isotype was predominant in not
only CD4+ T cells (Figure 1(a), middle of second row) but
also CD25+CD4+ T cells (Figure 1(a), right of second row;
62 ± 11% CD45RA+ and 21 ± 2% CD45RO+, n = 3). In
thymocytes, CD25+CD4+ T cells expressed both CD45RA
and CD45RO isotypes (Figure 1(a), right of bottom row;
35 ± 10% CD45RA+ and 46 ± 13% CD45RO+, n = 3),
similar to thymic total CD4+ T cells (Figure 1(a), middle
of bottom row). Meanwhile, all of the CD25+CD4+ Tc e l l s
expressedCD62L,regardlessoftheirexpressionofCD45RA+
or CD45RO+ (data not shown). It was clear from our
present data that CD45RA+ type CD25+CD4+ T cells was
predominant in CB while both CD45RA+ and CD45RO+
type CD25+CD4+ T cells existed in APB and Thy.
3.2. Lackofsuppressivefunctionof
CBCD25+CD4+ Tcells
We next determined the in vitro regulatory function of the
CD25+CD4+ populations derived from APB, CB, and Thy.
CD25+CD4+ T cells and CD25−CD4+ T cells were separated
using a magnetic microbead system, with Western blotting
for FOXP3 conﬁrming that Treg existed predominantly in
the CD25+CD4+ T cell preparations from APB, CB, and Thy
(Figure 2(a)). It was noted that FOXP3 protein levels were
diﬀerent among CD25+CD4+ T cells from APB, CB, or Thy
with the expression level being very weak in CD25+CD4+ T6 Clinical and Developmental Immunology
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Figure 3:SuppressiveeﬀectofCD4+CD25+ TcellsoncytokineproductionbyCD4+CD25− respondercells.CD4+CD25+ TcellsandCD4 +CD25−
responder cells were prepared by a magnetic microbead system. Cells were stimulated with anti-CD3/CD28-mAb-coated beads in the
presence of antigen-presenting cells. The supernatants were removed after 48 hours of incubation with either CD4+CD25+ T cells (black
bars), CD4+CD25− responder cells (white bars), and cocultured cells (gray bars). TGF-β level in supernatants was measured using ELISA,
and levels of other cytokines were measured using a cytometric bead array kit. Data are mean ±SD of 3 independent experiments.
cells from CB. We next evaluated the suppressive activity of
CD25+CD4+ T cells on autologous CD25−CD4+ Tc e l lp r o -
liferation induced by anti-CD3/CD28 mAb-coated beads, as
well as the proliferative activity of CD25+CD4+ T cells them-
selves by thymidine uptake (Figure 2(b)). CD25+CD4+ T
cellsfromAPBorThysuppressedproliferationofresponding
CD25−CD4+ T cells in the presence of autologous antigen-
presenting cells in a dose-dependent fashion, whereas a
lack of suppression was observed in CB CD25+CD4+ T
cells. Additionally, CB CD25+CD4+ T cells, but not APB or
Thy CD25+CD4+ T cells, proliferated well upon stimulation
with anti-CD3/CD28 mAb-coated beads. We simultaneously
evaluated IL-2 production status of CD25+CD4+ Tc e l l s
and responding CD25−CD4+ T cells from APB, CB, and
Thy (Figure 3). APB and Thy CD25+CD4+ T cells produced
much lower levels of IL-2 than responding APB and Thy
CD25−CD4+ T cells. On the contrary, CB CD25+CD4+ T
cells did produce substantial level of IL-2. Absolute level of
IL-2 production from responding CD25−CD4+ T cells was
highest in those from APB, followed by those from CB, being
lowest in those from Thy. In summary, our data indicated
that CD25+CD4+ T cells from CB were not in an anergic
state and did not possess biologically signiﬁcant suppressive
activity, in marked contrast to APB or Thy CD25+CD4+
T cells. In addition to IL-2 production, we examined the
production of various cytokines by CD25−CD4+ Tc e l l s
and CD25+CD4+ T cells as well as the suppressive eﬀect of
CD25+CD4+ T cells on cytokine productions by responding
CD25−CD4+ T cells (Figure 3). It should be noted that
responding CD25−CD4+ T cells from CB and Thy did
not produce high levels of cytokines except the suppressive
cytokine TGF-β, as compared to those produced by APB. InWakae Fujimaki et al. 7
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Figure 4: Weak expression of FOXP3 and CD152 proteins in CB CD25+CD4+ Tc e l l s .Mononuclear cells or thymocytes were multistained
with anti-CD4, anti-CD8, anti-CD25, anti-CD45RA, anti-FOXP3, and anti-CD152 Abs (Table 1). The proﬁles were gated for CD8−CD4+,
and showed expression of CD25 versus endogenous FOXP3 (top panel) or CD152 (bottom panel). Additional gating was set on FOXP3 or
CD152 positive cells. Data are representative of 3 diﬀerent donors.
particular, CB and thymic cells did not produce detectable
levels of IL-4 or IL-5. While CD25+CD4+ T cells from APB
and Thy produced much lower levels of IL-2, IFN-γ or
TNFα as compared to those produced by responding cells,
CB CD25+CD4+ T cells secreted substantial levels of these
cytokines. Furthermore, CD25+CD4+ T cells from APB, CB,
or Thy did not produce high level of the suppressive cytokine
IL-10, but secreted high level of TGF-β. While CD25+CD4+
T cells suppressed the production of IL-2, IFN-γ,a n dT N F α,
this suppressive activity was much weaker in CB compared
to APB and Thy. Notably, CD25+CD4+ T cells from all three
compartments did not suppress the production of TGF-β.
3.3. WeakexpressionFOXP3andCD152on
CD25+CD4+ TcellsfromCB
The expression of FOXP3 and CD152 is associated closely
with Treg function [6, 8–10, 12, 28, 29]. As shown
in Figure 2(a), FOXP3 protein was detected only in
CD25+CD4+ T cells from all three compartments, although
being weaker in CB CD25+CD4+ T cells than APB or
Thy CD25+CD4+ T cells. We next analyzed endogenous
FOXP3 and CD152 protein expression by ﬂow cytometry
(Figure 4). Mononuclear cells and thymocytes were evalu-
ated by multicolor analysis. FOXP3 expression was analyzed
withdatafromlowerintracellularstainingpatterninTable 1,
and CD152 expression with data from upper intracellular
staining pattern. We found that protein expression level
of FOXP3 and CD152 correlated with that of CD25, with
higher CD25 expression associated with higher endogenous
level of FOXP3 or CD152, and demonstrated that the mean
ﬂuorescence level of FOXP3 (99 ± 33 APB, 25 ± 10 CB and
82 ± 42 Thy, n = 3) or CD152 (46 ± 31 APB, 16 ± 1C Ba n d
55 ± 7T h y ,n = 3) was weaker in CB than that in APB and
Thy.Insummary,theproteinexpressionlevelofbothFOXP3
and CD152 was clearly weaker in CD25+CD4+ Tc e l l sf r o m
CB than those from APB and Thy, consistent with the lack of
suppressive activity of CB CD25+CD4+ T cells.
3.4. CD45isotypeandTregfunction
Our data showed that CD25+CD4+ T cells from CB,
which preferentially expressed the CD45RA+ phenotype,
showed a lack of suppressive activity compared to APB8 Clinical and Developmental Immunology
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Figure 5: Weak suppressive activity and expression of FOXP3 and CD152 proteins by CD45RA+ type APB CD25+CD4+ Tc e l l s .(a)
CD45RA+CD25+CD4+, CD45RA−CD25+CD4+,a n dC D 2 5 −CD4+ cells were sorted and incubated under the indicated conditions as
described in Section 2. Cell proliferation was assessed by 3H-thymidine uptake on day 4. Data are representative of 3 diﬀerent donors. (b)
Mononuclear cells from APB were multistained with anti-CD4, anti-CD8, anti-CD25, anti-CD45RA, anti-FOXP3, and anti-CD152 Abs as
described in Table 1. The proﬁles were gated initially for CD8−CD4+, then CD45RA− type or CD45RA+ type CD25+CD4+ Tc e l l sw e r eg a t e d
basedontheexpressionofCD45RAandCD25inpanel(a).TheexpressionsofCD25versusendogenousFOXP3orCD152inCD45RA− type
(panels (b) and (c)) or CD45RA+ type CD25+CD4+ T cells (panels (d) and (e)) were merged as blue dots to those in CD8−CD4+ cells (red
dots in panels (b)–(e)). Data are representative of 10 diﬀerent donors. (c) Mononuclear cells or thymocytes were multistained as described
in Figure 4(b). On the basis of FOXP3 expression, FOXP3high or FOXP3low was gated (panels (a), (d), (f)). In each population, histogram of
CD45RA expression was shown (panels (b), (c), (e), (g), (h)).
CD25+CD4+ T cells, which contained both CD45RA+ and
CD45RO+subsets. To deﬁne whether CD45RA+-expressing
APB CD25+CD4+ T cells and CB CD25+CD4+ Tc e l l s
exhibited the same levels of suppressive activity, we com-
pared the suppressive activity of CD45RA+ type APB
CD25+CD4+ T cells, CD45RA− type APB CD25+CD4+ T
cells, and CB CD25+CD4+ T cells (Figure 5(a)). CD45RA−
type APB CD25+CD4+ T cells, which mainly consisted
of CD45RO+CD25+CD4+ T cells, showed high suppres-
sive activity and were themselves in an anergic state.
Meanwhile, the CD45RA+ type APB CD25+CD4+ Tc e l l s
showed less suppressive activity than the CD45RA− type
APB CD25+CD4+ T cells and were found mostly in an
anergic state, although capable of proliferation to some
e x t e n t .H o w e v e r ,C BC D 2 5 +CD4+ T cells did not show any
suppressive activity and were not in an anergic state.
Since it has been reported that suppressive activity of
Treg is associated with its expression of FOXP3 protein
[8, 9], we next assessed the endogenous expression of FOXP3
and CD152 in CD45RA+ and CD45RA− type CD25+CD4+
T cells from APB using the lower intracellular staining
pattern in Table 1. Figure 5(b) shows the expression proﬁlesWakae Fujimaki et al. 9
of CD45RA versus CD25 (square gates in panel (a)),
FOXP3 versus CD25 (blue dots in panels (b) and (d)),
or CD152 versus CD25 (blue dots in panels (c) and (e))
among CD8−CD4+ T cells (red dots in panels (b)–(e)).
APB CD45RA− type CD25+CD4+ T cells showed a wide
range of FOXP3 (MFI = 86; blue dots in panel (b) of
Figure 5(b)) and CD152 (MFI = 40; blue dots in panel (c) of
Figure 5(b)) expression, while CD45RA+ type CD25+CD4+
T cells exhibited only weak expression of FOXP3 (MFI = 33;
blue dots in panel (d) of Figure 5(b)) and CD152 (MFI = 19;
blue dots in panel (e) of Figure 5(b).
To further assess the relationship between CD45 iso-
type expression and Treg, we analyzed CD45RA expres-
sion in relation to FOXP3 expression (Figure 5(c)). APB
CD25+CD4+ T cells expressing high level of FOXP3 (panel
(a)) were CD45RA− (panel (c)), while CD25+CD4+ T
cells with low FOXP3 expression (panel (a)) consisted
of both CD45RA+cells and CD45RA− cells (panel (b)).
Meanwhile, CB CD25+CD4+ T cells were weakly FOXP3
positive (panel (d)) and were mainly CD45RA+cells (panel
(e)). Thymic CD25+CD4+ T cells contained both CD45RA+
and CD45RA− cells, regardless of the intensity of FOXP3
expression (panels (f)–(h)).
Taken together, our data suggested that Treg function
was correlated with the FOXP3 expression level and CD45
isotype.
3.5. Restorationofsuppressiveactivityin
expandedCBCD25+CD4+ Tcells
Freshly isolated CB CD25+CD4+ T cells, exhibiting the
CD45RA+ phenotype, lacked suppressive activity in our
experimental system. We next examined the suppressive
activity, CD45RA expression, and FOXP3 protein level of
CD25+CD4+ T cells prior to and following in vitro activa-
tion. As shown in Figure 6(a),e x p a n d e dC BC D 2 5 +CD4+
T cells showed excellent suppressive activity and were in
a complete anergic state, while fresh CB CD25+CD4+ T
cells were not in an anergic state and did not possess any
suppressive activity (Figure 2(b)). Likewise, expanded APB
and Thy CD25+CD4+ T cells displayed greater suppressive
activity than freshly isolated CD25+CD4+ T cells, although
the diﬀerence was not as prominent as compared to that
observed in CB (Figure 6(a)). Notably, the phenotype of Thy
CD25+CD4+ T cells shifted from CD45RA− to CD45RA+
following expansion, whereas CD25+CD4+ Tc e l l sf r o mC B
and APB shifted from CD45RA+ to CD45RA− (Figure 6(b)).
Meanwhile, FOXP3 expression increased following the
expansion of CD25+CD4+ T cells from APB, CB, and
Thy (Figure 6(c)). The enhancement in FOXP3 level was
especially prominent in the expanded CB CD25+CD4+ T
cells population, consistent with the marked increase in
suppressive activity (Figures 6(a) and 6(c)). Of note was also
the fact that the responding CD25−CD4+ cells from Thy
became FOXP3 positive following the expansion in culture
(Figure 6(c)). Our ﬁndings thus indicated that expansion of
CB CD25+CD4+ T cells resulted in the restoration of potent
suppressive activity and an anergic state, associated with a
concomitant increase in FOXP3 expression and a shift from
the CD45RA+ to CD45RA− phenotype.
4. DISCUSSION
To deﬁne the regulatory function of human Treg in each
stage of maturation, we compared the phenotype and
regulatory function of CD25+CD4+ T cells from Thy, CB,
and APB. In this study, we have demonstrated that the
suppressive function of fresh CB CD25+CD4+ T cells was
lacking in contrast to APB CD25+CD4+ Tc e l l sa n dT h y
CD25+CD4+ T cells, and subsequent expansion of the CB
CD25+CD4+ T cells population resulted in the restoration
of its suppressive activity. The observed diﬀerence in Treg
function in CD25+CD4+ T cells from Thy, CB, and APB was
associated with alteration in the CD45 isotype and FOXP3
expression level.
We demonstrated herein that the lack of functional
activitywassolelyobserv edinCBCD25 +CD4+ Tcells,which
weakly expressed FOXP3 and CD152, showed no suppressive
activity and were not in an anergic state (Figures 2 and 4).
While previous studies have examined the function of Thy,
CB, or APB Treg, interpretation of the observed results may
be complicated by diﬀerences in experimental conditions
[15–17, 19]. For example, Wing et al. reported that CB
Treg suppressed proliferation by CD25− T cells stimulated
with myelin oligodendrocyte glycoprotein (MOG) but not
with staphylococcus enterotoxin B (SEB) [19], while an
earlier study by the same group showed that CD25+
Treg did not suppress MOG-induced proliferation [30].
On the other hand, other groups demonstrated suﬃcient
suppressive activity by CB Treg as compared to APB Treg
following stimulation with PHA or anti-CD3 mAb [16, 17].
Moreover, Thornton et al. showed that fresh CB Treg did not
display suppressive activity in mixed lymphocyte reaction
system in contrast to the suppressive activity seen in CB
Treg cultured with ovalbumin [15]. Therefore, it is unclear
whether or not antigen-speciﬁc eﬀector and regulatory T
cells are present in CB, or whether SEB provides a T cell
receptor (TCR-) mediated signal of suﬃcient strength to
render CD25− T cells refractory to inhibition by CD25+
Treg. To address these issues, our present work compared the
functions of CD25+CD4+ T cells from the Thy, CB, and APB
compartments together in the same experimental system,
using the combination of anti-CD3-mAb plus anti-CD28-
mAb as the standard TCR stimulants. However, we could not
formally exclude the possibility that nonregulatory CD25+ T
cellsinisolatedTregfraction,ornoneﬀectorCD25− Tcellsin
isolated responding CD25− T cell fraction, might contami-
natethecellfractionofinterestatanundetectablelevel,since
isolationofcellswasconductedbymagneticbeadseparation.
Cytokine proﬁles of APB Treg were previously reported
by some investigators [31, 32], and other investigators
reported production of IFN-γ and IL-10 by CB Treg or Thy
Treg [19]. In general, previous studies demonstrated that
Treg did not produce IL-2 and IFN-γ, as was also the case
with our present data with APB and Thy CD25+CD4+ T
cells (Figure 3). On the other hand, we observed that CB
CD25+CD4+ T cells produced substantial levels of IL-2 and10 Clinical and Developmental Immunology
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Figure 6: Restoration of suppressive activity in expanded CB CD25+CD4+ Tc e l l s .(a) Freshly isolated CD4+CD25+ cells were used as Treg in
Figure 2(b), and expanded as described in Section 2. Freshly isolated CD25−CD4+ T cells were used as responder cells in both primary and
secondary assays without expansion. Cell proliferation was assessed by 3H-thymidine uptake on day 4. Data are obtained by experiments
withsamplesof3diﬀerent donors. (b) Freshly isolated CD4+CD25+ cells or expanded CD4+CD25+ cells were stained with anti-CD3, CD25,
and CD45RA, and analyzed using FACSCalibur. The cells were gated for CD3+CD25+ cells and the expression of CD45RA was compared
between freshly isolated CD4+CD25+ cells (open histogram) and expanded CD4+CD25+ cells (closed histogram). Data are representative of
3d i ﬀerent donors. (c) Expression of FOXP3 protein was compared between freshly isolated cells and expanded cells by Western blot. Data
are representative of 3 diﬀerent donors.
IFN-γ and did not inhibit cytokine production by responder
cells suﬃciently, consistent with our observation of their
lack of suppressive activity on responder cell proliferation.
Notably, the suppressive cytokine TGF-β was produced by
both CD25+CD4+ T cells and responder cells in all of the
APB, CB, and Thy compartments, while IL-10 and TGF-
β production was prominent in Thy. Although it might be
argued that various cytokines may be produced by T cells
in response to diﬀerent in vitro stimulants, our observation
shown in Figure 3 suggests that the Treg population may be
maintained in some circumstances by IL-10 and/or TGF-β,
consistent with previous work showing a role for TGF-β in
the in vivo expansion of Treg [33].
As shown in Figure 5(a), we demonstrated that the
suppressive activity of CD45RA+ type APB CD25+CD4+ T
cells was between that of CD45RA− type APB CD25+CD4+
T cells and CB CD25+CD4+ T cells. Furthermore, cellular
expression of the FOXP3 protein in CD45RA+ type APB
CD25+CD4+ T cells was low and clearly diﬀerent from that
of CD45RA− type APB CD25+CD4+ T cells (Figure 5(b)).
These observations suggested that CD45RA+ type APB
CD25+CD4+ Tc e l l sw e r ed i ﬀerent compared with CB
CD25+CD4+ T cells, being mostly CD45RA+,a sw e l la s
being diﬀerent compared with CD45RA−APB CD25+CD4+
T cells. Wing et al. have shown that CD45RA+CD25+ Tc e l l s
are comprised of approximately two-third of the CD25+ TWakae Fujimaki et al. 11
cells and corresponded to cells with a regulatory and na¨ ıve
phenotype expressing intracellular CTLA-4 and CD122. The
remaining one-third of the CD25+ T cells were CD45RA−,
CD62Llow, CD38low, CD122low,C T L A - 4 − and might consti-
tute eﬀector T cells [18]. However, CB CD25+CD45RA− T
cells expressed foxp3 mRNA although at lower levels than T
cells with a regulatory phenotype [19]. As these data were
obtained by quantitative RT-PCR assay for foxp3 mRNA, it
was possible that the level of foxp3 mRNA did not directly
correlate with the CB Treg function. Regarding this issue,
we sorted the CD25+ T cells by FACS into subpopulations
diﬀering in intracellular FOXP3 protein levels. As shown
in Figure 5(c), we observed that CB FOXP3+CD4+ T cells,
w h i c hw e r ea l lF O X P 3 low, consisted mainly of CD45RA+ T
cells, and that APB FOXP3low CD4+ T cells did not coexpress
CD45RA+ at all. These ﬁndings would suggest a potential
relationship between the change in FOXP3 expression and
CD45 isoform switching during T cell development.
Regarding the relevance of our ﬁndings to fetomaternal
immunology, it is an issue that needs to be considered
based on our observation that the suppressive activity of CB
CD25+CD4+ T cells was at a very low level compared to that
of APB CD25+CD4+ T cells (Figures 2 and 3). The placental
barrier does not completely separate fetus and mother, with
immunocomponent cells being able to cross this barrier
in both directions [34]. The immunotolerant behavior of
the mother toward the fetus is known to be necessary
for survival, and it is equally important for the fetus
torecognize and eliminate maternal immunocomponent
cells as immunologic defense against maternal cell attack
[35,36].Itisthereforeareasonablepossibilitythatfunctional
downregulation of CB Treg is associated with fetomaternal
immune balance in pregnancy. On the other hand, the
suppressive activity of CB Treg is exerted after stimulation
of CB CD4+CD25+ T cells via TCR plus CD28 signaling
(Figure 6).ThisresultmayexplaintheobservationthatHLA-
mismatched allogeneic transplantation, which can result in
severe graft-versus-host disease (GVHD) in bone marrow or
peripheralbloodstemcelltransplantation,ispossibleincord
blood transplantation with tolerable GVHD [37]. Moreover,
an increase in CB Treg suppressive activity following cellular
stimulation may reduce the risk of developing autoimmune
and allergic diseases after birth.
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